Will Healy

Will Healy

Will Healy is a freelance financial writer. He had a lifelong interest in the stock market, trading equities since the dot-com boom. Will pursued his passion for writing after working in the corporate world as both an analyst and an insurance sales professional. He likes to approach the market by focusing on deep value, dividends, and speculation.

Will’s writing has focused on stock analysis, as well as real estate, insurance, personal finance, macroeconomics, and politics. Along with InvestorPlace, his work has appeared on numerous sites, including Seeking Alpha, Yahoo! Finance, MSN Money, Kiplinger Tax Letter, and GOBankingRates. He holds both a B.S. in Journalism and an MBA in finance and strategy.

Recent Articles

Recent Deals Will Help Salesforce More Than They Will Salesforce Stock

Salesforce.com stock has many fundamental positives, including key buyouts and partnerships. Still, the multiple compression is a worrisome point as the company’s shares have been elevated for quite some time.

CSX Stock Will Likely Continue to Fall Amid Economic Uncertainty

CSX stock price dropped sharply after its results, and a likely slowdown in the economy and a trade war could still derail CSX stock.

GWPH Stock: Expect the Unexpected Coming Into Earnings

Admittedly, GWPH stock could go either way before earnings. The sector in general has suffered amid falling prices for dried cannabis. With valuations still elevated, GWPH may need to offer a “perfect” report to keep the stock price from falling.

CVS Stock Is Worth Buying Ahead of Its Earnings

CVS stock is facing multiple headwinds, but CVS stock price has now reached attractive levels ahead of earnings..

Alphabet Stock Is Still Not Reaping the Benefits of the Company’s Growth

Although a stellar earnings report gave Alphabet stock a huge boost, Alphabet continues to lock away the real value of GOOGL stock.

7 Recession-Proof Stocks to Buy as the Boom Ends

If you're looking for some recession-proof stocks that should serve investors well in harder times, you could do a lot worse than these 7 names.

Not Even Market Leadership Can Slow the Canopy Growth Stock Slide

CGC will probably remain the leading marijuana stock, but the CEO firing and the supply glut will continue to hurt Canopy Growth stock.

Hexo Stock Has a Future, but You Don’t Want to Own It Just Yet

HEXO stock holds the potential to join the top tier of marijuana stocks, but Hexo Corp stock may have become the victim of industry trends.

Economy, Politics Will Always Preclude High Valuations in iQiyi Stock

iQiyi should continue to grow revenues, but a declining Chinese economy coupled with the nature of the equity could dampen growth in IQ stock.

Sealed Air Will Probably Beat on Earnings, But That Won’t Save SEE Stock

SEE stock may post flat growth this quarter. Although that should improve in future quarters, traders face a history of range-bound trading.